Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-583 Phase 2 in Diabetic Peripheral Neuropathy
NCT00760955Phase 2Completed
- Sponsor
- Takeda
- Start
- Sep 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of TAK-583 in diabetic peripheral neuropathy (DPN), sponsored by Takeda. Started Sep 2006; status: completed.
02
Drugs
TAK-583
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00760955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00760955.